在中国,人工智能驱动的2型糖尿病管理:机遇和挑战
1Shanghai Xuhui Area Government of Community Office of Kangjian Xincun Street, Shanghai, People's Republic of China.
Diabetes, metabolic syndrome and obesity : targets and therapy
|January 13, 2025
概括
人工智能 (AI) 在中国为2型糖尿病 (T2D) 管理提供了巨大的潜力,改善了个性化治疗,监测和远程医疗. 人工智能集成有望彻底改变糖尿病护理,尽管存在挑战.
科学领域:
- 内分泌学 在内分泌学.
- 医疗信息学 医疗信息学
- 公共卫生 公共卫生
背景情况:
- 由于人口老龄化和生活方式的变化,中国的2型糖尿病 (T2D) 患病率正在上升.
- 二型糖尿病对中国的公共卫生系统构成重大挑战.
- 需要创新的管理策略来应对日益增长的T2D负担.
研究的目的:
- 在中国背景下,探索人工智能 (AI) 在2型糖尿病管理中的应用和有效性.
- 确定人工智能在T2D护理中的潜在好处和挑战.
- 预测人工智能在中国和全球糖尿病管理中的未来作用.
主要方法:
- 在T2D管理中审查和分析当前的AI应用.
- 探索AI在个性化治疗,实时监控,远程医疗和健康管理方面的能力.
- 考虑包括数据隐私,技术采用,标准化和监管在内的挑战.
主要成果:
- 人工智能在提高T2D治疗的精度和方便性方面显示出巨大的潜力.
- 人工智能有助于实时监控,预警系统和有效的并发症管理.
- 人工智能应用在远程医疗和T2D患者的综合健康管理方面表现有前途.
结论:
- 人工智能技术将在中国的T2D管理中发挥越来越重要的作用.
- 克服数据隐私,普及,标准化和监管方面的挑战对于人工智能采用至关重要.
- 部门间的合作,政策支持和文化适应将推动人工智能在全球糖尿病护理方面的革命性影响.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
32
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32


